Create account / Login
Score: n/a SD: (n/a)

Open Statement: TNF-alpha

Subgroup: other

Posted by Thomas Maurer

  Title Author Journal Year Paper
level
(mean)
Readers
vote
(mean)
Number of
Voters
 
1 Trefoil factor 3 is induced during degenerative and inflammatory joint disease, activates matrix metalloproteinases, and enhances apoptosis of articular cartilage chondrocytes. Rösler, Sophie; Haase, Tobias; Claassen, Horst; Schulze, Ute; Schicht, Martin; Riemann, Dagmar; Brandt, Jörg; Wohlrab, David; Müller-Hilke, Brigitte; Goldring, Mary B; Sel, Saadettin; Varoga, Deike; Garreis, Fabian; Paulsen, Friedrich P; Arthritis and rheumatism 2010 0.00 0.00 0
2 Rheumatoid arthritis disease-modifying antirheumatic drug intervention and utilization study: safety and etanercept utilization analyses from the RADIUS 1 and RADIUS 2 registries. Gibofsky, Allan; Palmer, William R; Keystone, Edward C; Schiff, Michael H; Feng, Jingyuan; McCroskery, Peter; Baumgartner, Scott W; Markenson, Joseph A; The Journal of rheumatology 2011 0.00 0.00 0
3 High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand. Lohachanakul, Jindarat; Phuklia, Weerawat; Thannagith, Montri; Thonsakulprasert, Tipparat; Ubol, Sukathida; Microbiology and immunology 2012 0.00 0.00 0
4 Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. Proulx, Steven T; Kwok, Edmund; You, Zhigang; Papuga, M Owen; Beck, Christopher A; Shealy, David J; Ritchlin, Christopher T; Awad, Hani A; Boyce, Brendan F; Xing, Lianping; Schwarz, Edward M; Arthritis and rheumatism 2007 0.00 0.00 0
5 TNF-? antagonists beyond approved indications: stories of success and prospects for the future. Karampetsou, M P; Liossis, S-N C; Sfikakis, P P; QJM : monthly journal of the Association of Physicians 2010 0.00 0.00 0
6 Whole-body deletion of LPS-induced TNF-? factor (LITAF) markedly improves experimental endotoxic shock and inflammatory arthritis. Merrill, Jamie C; You, Jian; Constable, Cara; Leeman, Susan E; Amar, Salomon; Proceedings of the National Academy of Sciences of the United States of America 2011 0.00 0.00 0
7 Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA). Friese, M A; Hellwage, J; Jokiranta, T S; Meri, S; Müller-Quernheim, H J; Peter, H H; Eibel, H; Zipfel, P F; Clinical and experimental immunology 2000 0.00 0.00 0
8 [Non tuberculous anti-TNF associated opportunistic infections]. Marie, I; Guglielmino, E; La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2010 0.00 0.00 0
9 Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. Otten, Marieke H; Prince, Femke H M; Armbrust, Wineke; ten Cate, Rebecca; Hoppenreijs, Esther P A H; Twilt, Marinka; Koopman-Keemink, Yvonne; Gorter, Simone L; Dolman, Koert M; Swart, Joost F; van den Berg, J Merlijn; Wulffraat, Nico M; van Rossum, M JAMA : the journal of the American Medical Association 2011 0.00 0.00 0
10 Whipple's disease diagnosis following the use of TNF-? blockade. Gaddy, Jasmine R; Khan, Zartash Z; Chaser, Brad; Scofield, R Hal; Rheumatology (Oxford, England) 2011 0.00 0.00 0
11 Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics. Kawashiri, Shin-ya; Kawakami, Atsushi; Iwamoto, Naoki; Fujikawa, Keita; Aramaki, Toshiyuki; Tamai, Mami; Arima, Kazuhiko; Ichinose, Kunihiro; Kamachi, Makoto; Yamasaki, Satoshi; Nakamura, Hideki; Origuchi, Tomoki; Ida, Hiroaki; Eguchi, Katsumi; Modern rheumatology / the Japan Rheumatism Association 2010 0.00 0.00 0
12 Towards the next generation of anti-TNF drugs. Sfikakis, Petros P; Tsokos, George C; Clinical immunology (Orlando, Fla.) 2011 0.00 0.00 0
13 Genotype, phenotype, and clinical course in five patients with pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome. Demidowich, Andrew P; Freeman, Alexandra F; Kuhns, Douglas B; Aksentijevich, Ivona; Gallin, John I; Turner, Maria L; Kastner, Daniel L; Holland, Steven M; Arthritis and rheumatism 2011 0.00 0.00 0
14 Permanent renal loss following tumor necrosis factor ? antagonists for arthritis. Chen, Tzu-Jen; Yang, Ya-Fei; Huang, Po-Hao; Lin, Hsin-Hung; Huang, Chiu-Ching; Rheumatology international 2010 0.00 0.00 0
15 Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection. Jones, Dallas; Glimcher, Laurie H; Aliprantis, Antonios O; The Journal of clinical investigation 2011 0.00 0.00 0
16 Multicentric reticulohistiocytosis associated arthritis responding to anti-TNF and methotrexate. De Knop, K J; Aerts, N E; Ebo, D G; Van Offel, J F; Stevens, W J; De Clerck, L S; Acta clinica Belgica 2011 0.00 0.00 0
17 Whole-body deletion of LPS-induced TNF-? factor (LITAF) markedly improves experimental endotoxic shock and inflammatory arthritis. Merrill, Jamie C; You, Jian; Constable, Cara; Leeman, Susan E; Amar, Salomon; Proceedings of the National Academy of Sciences of the United States of America 2011 0.00 0.00 0
18 Septic versus inflammatory arthritis: discriminating the ability of serum inflammatory markers. Talebi-Taher, Mahshid; Shirani, Fatemeh; Nikanjam, Najmeh; Shekarabi, Mehdi; Rheumatology international 2012 0.00 0.00 0
19 Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry. Pérez-Sola, María José; Torre-Cisneros, Julián; Pérez-Zafrilla, Beatriz; Carmona, Loreto; Descalzo, Miguel Angel; Gómez-Reino, Juan Jesús; , ; Medicina clínica 2011 0.00 0.00 0
20 Paracoccidioidomycosis Induced by Immunosuppressive Drugs in a Patient with Rheumatoid Arthritis and Bone Sarcoma: Case Report and Review of the Literature. Woyciechowsky, Tiago G; Dalcin, Diogo C; Dos Santos, José Wellington A; Michel, Gustavo T; Mycopathologia 2011 0.00 0.00 0
21 Efficacy of serum angiopoietin-1 measurement in the diagnosis of early rheumatoid arthritis. Ishikawa, A; Okada, J; Nishi, K; Hirohata, S; Clinical and experimental rheumatology 2011 0.00 0.00 0
22 T. asahii pulmonary infection as a complication of TNF-inhibitor and steroids: posaconazole pharmacotherapy and risk analysis. Songcharoen, Somjade; Cleary, John D; Jenkins, John; DeShazo, Matthew; Journal of the Mississippi State Medical Association 2012 0.00 0.00 0
23 Whipple's disease endocarditis following anti-TNF therapy for atypical rheumatoid arthritis. Ansemant, Thiphaine; Celard, Marie; Tavernier, Christian; Maillefert, Jean-Francis; Delahaye, François; Ornetti, Paul; Joint, bone, spine : revue du rhumatisme 2010 0.00 0.00 0
24 Honokiol: an effective inhibitor of tumor necrosis factor-?-induced up-regulation of inflammatory cytokine and chemokine production in human synovial fibroblasts. Li, Jie; Shao, Xueting; Wu, Lijuan; Feng, Tingting; Jin, Changzhong; Fang, Meixin; Wu, Nanping; Yao, Hangping; Acta biochimica et biophysica Sinica 2011 0.00 0.00 0
25 Rheumatoid arthritis and periodontitis - inflammatory and infectious connections. Review of the literature. Rutger Persson, G; Journal of oral microbiology 2012 0.00 0.00 0

Back to questionlist